Your browser version may not work well with NCBI's Web applications. More information here...
Related Articles, Links

Morphine-6-glucuronide, a potent mu agonist.

Pasternak GW, Bodnar RJ, Clark JA, Inturrisi CE.

Cotzias Laboratory of Neuro-Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY.

The 3- and the 6-glucuronides of morphine have been examined in binding studies and in vivo. The 3-glucuronide had poor affinity in all binding studies whereas the 6-glucuronide potently labeled mu, but not delta or kappa receptors with affinities similar to morphine. Microinjections of the 3-glucuronide directly into the periaqueductal gray were without effect. The 6-glucuronide, on the other hand, was up to 20-fold more potent than morphine following microinjections in the same region. High doses of the 6-glucuronide produced profound seizure activity. All 6-glucuronide actions were sensitive to the opiate antagonist naloxone.

Publication Types:
PMID: 2826951 [PubMed - indexed for MEDLINE]